TATACHEM612.00

Tata Chemicals Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersGHCLAARTIINDJGCHEMCHAMBLFERTNAVINFLUORDEEPAKFERTHSCLNOCILMcap ₹15,606 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations15,421.014,887.014,584.015,120.0
Other Income286.0225.0316.0276.0
Total Income15,707.015,112.014,900.015,396.0
Expenses
+ Cost of Materials Consumed2,710.02,560.02,958.03,018.0
+ Purchases of Stock-in-Trade232.0290.0305.0303.0
+ Changes in Inventories-241.028.0-79.0-11.0
+ Employee Benefit Expense1,860.01,989.02,060.02,088.0
+ Finance Costs530.0563.0590.0591.0
+ Depreciation & Amortisation980.01,123.01,201.01,257.0
+ Other Expenses8,013.08,067.07,535.08,011.0
Total Expenses14,084.014,620.014,570.015,257.0
EBITDA2,847.01,953.01,805.01,711.0
EBIT1,867.0830.0604.0454.0
Profit
PBT before Exceptional Items1,623.0492.0330.0139.0
+ Exceptional Items-861.0-125.0-1,956.0-1,956.0
Pretax Income762.0367.0-1,626.0-1,817.0
+ Current Tax260.0126.0172.0164.0
+ Deferred Tax121.041.084.098.0
Tax Expense381.0167.0256.0262.0
+ Share of Associates & JVs68.0154.0167.0108.0
Net Income435.0387.0-1,715.0-1,971.0
+ Net Income — Continuing Ops381.0200.0-1,882.0-2,079.0
+ Net Income — Discontinued Ops-14.033.00.00.0
+ Other Comprehensive Income2,814.0-501.01,790.01,956.0
Total Comprehensive Income3,249.0-114.075.0-15.0
Net Income to Common268.0235.0-1,896.0-2,165.0
Minority Interest167.0152.0181.0194.0
Per Share
Basic EPS10.529.23-74.42-77.68
Diluted EPS10.529.23-74.42-77.68
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax-14.047.00.00.0
+ Tax — Discontinued Operations0.014.00.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-501.01,790.01,956.0
+ Items NOT to be Reclassified to P&L3,041.0-668.01,036.01,144.0
+ Tax on Items NOT to be Reclassified80.0109.050.0
+ Tax on Items NOT to be Reclassified — alt tag375.0
+ Items to be Reclassified to P&L171.0258.0858.0863.0
+ Tax on Items to be Reclassified11.0-5.01.0
+ Tax on Items to be Reclassified — alt tag23.0
Comprehensive Income — Owners of Parent3,082.0-265.0-108.0-211.0
Comprehensive Income — Non-controlling Interests167.0151.0183.0196.0
Per Share — as-filed variants
Basic EPS — Continuing Operations11.077.93-74.42-77.68
Diluted EPS — Continuing Operations11.077.93-74.42-77.68
Basic EPS — Discontinued Operations-0.551.300.000.00
Diluted EPS — Discontinued Operations-0.551.300.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit12,720.012,009.011,400.011,810.0
Gross Margin %82.4880.6778.1778.11
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)1,623.0492.0330.0139.0
− Exceptional Items (reconciliation)-861.0-125.0-1,956.0-1,956.0
Net Income Adj (tax-effected)865.5455.1241.0-15.0
EPS Adj20.9310.8510.46-0.59
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital255.0255.0255.0255.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.